skip to Main Content

Meet the Committee Members

The Women’s Venture Competition review committees are comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the National Foundation for Cancer Research, the non-profit affiliate of the AIM-HI Accelerator Fund.

This competition is designed to provide women scientist-entrepreneurs with advising, coaching and continuous access to our valuable global network to advance their innovative oncology technologies that can save patients’ lives. Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Judging Committee:

Pamela Garzone, Ph.D. | Co-Chair

Pamela Garzone, Ph.D. | Co-Chair

Chief Development Officer, Anixa Biosciences

Raju Kucherlapati, Ph.D. | Co-Chair

Raju Kucherlapati, Ph.D. | Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Webster Cavenee, Ph.D.

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Aleksandra Filipovic, M.D., Ph.D.

Aleksandra Filipovic, M.D., Ph.D.

Head of Oncology, PureTech Health

Jennifer Grandis, M.D.

Jennifer Grandis, M.D.

American Cancer Society Professor, University of California San Francisco

Brian Leyland-Jones, MBBS, Ph.D.

Brian Leyland-Jones, MBBS, Ph.D.

Chief Medical Officer, AIM-HI Accelerator Fund

Scott Lippman, M.D.

Scott Lippman, M.D.

Director, Moores Cancer Center, UC San Diego Health

Beverly Lu, Ph.D.

Beverly Lu, Ph.D.

Investment Manager, Health, Emerson Collective

Eva Martin, M.D.

Eva Martin, M.D.

Data Strategy Lead – Clinical, Roche Diagnostic Solutions

Tom Miller

Tom Miller

Founder & Managing Partner, GreyBird Ventures

Selection Committee:

Pamela Garzone, Ph.D. | Co-Chair

Pamela Garzone, Ph.D. | Co-Chair

Chief Development Officer, Anixa Biosciences

Raju Kucherlapati, Ph.D. | Co-Chair

Raju Kucherlapati, Ph.D. | Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Webster Cavenee, Ph.D.

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Aleksandra Filipovic, M.D., Ph.D.

Aleksandra Filipovic, M.D., Ph.D.

Head of Oncology, PureTech Health

Dimitra Georganopoulou, Ph.D.

Dimitra Georganopoulou, Ph.D.

Innovation Faculty, MIT linQ CATALYST

Brian Leyland-Jones, MBBS, Ph.D.

Brian Leyland-Jones, MBBS, Ph.D.

Chief Medical Officer, AIM-HI Accelerator Fund

Scott Lippman, M.D.

Scott Lippman, M.D.

Director, Moores Cancer Center, UC San Diego Health

Michael Salgaller, Ph.D.

Michael Salgaller, Ph.D.

Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute

Fei Shen, Ph.D.

Fei Shen, Ph.D.

Managing Director, Boehringer Ingelheim Venture Fund USA

Investment Committee:

Jimmy Lu, J.D., MBA | Chair

Jimmy Lu, J.D., MBA | Chair

Co-Founder, R3 Bio

Patty Obermaier

Patty Obermaier

Vice President, US Health and Life Sciences, Microsoft

Chih-Kao Hu, Ph.D., MBA

Management Consultant, Qral Group

Kim Kamdar, Ph.D.

Kim Kamdar, Ph.D.

Managing Partner, Medical Excellence Capital

Monica Bertagnolli, M.D. | Co-Chair

Monica Bertagnolli, M.D. | Co-Chair

Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology, Harvard Medical School

Robert Tepper, M.D.

Robert Tepper, M.D.

Partner, Third Rock Ventures

Yajun Xu, Ph.D.

Yajun Xu, Ph.D.

Managing Partner, Hongsen Capital

Michael Wang, M.D., Ph.D., MBA

Michael Wang, M.D., Ph.D., MBA

Chief Science Officer, AIM-HI Accelerator Fund

Thea Tlsty, Ph.D.

Thea Tlsty, Ph.D.

Professor of Pathology, University of California San Francisco

Matt Tremblay, Ph.D.

Matt Tremblay, Ph.D.

Chief Operating Officer, Scripps Research

Huijun (HJ) Yang, Ph.D.

Huijun (HJ) Yang, Ph.D.

President, Yang Management, Inc.

Back To Top